HEP-1 (Human Ezrin peptide) – 10MG per vial

Clinical Test Expectation HEP-1 – Human Subjects :Covid-19 treatment. Ulcerative colitis treatment and Hepatitis -C treatment
Strength – 10MG per vial

Introduction
Currently, SARS-CoV-2 the novel member of the corona virus family, affecting the world leading to COVID-19 disease. It can result life-threatening condition by developing severe acute respiratory distress syndrome (ARDS). Based on previous evidence a group of patients with severe COVID-19 develop a cytokine storm syndrome which leads to hyper-inflammation lung tissue damage. Supportive care is the current management of COVID-19 is and management of ARDS as a main cause of mortality has been remained challenging. Therefore, an urgent effective treatment of COVID-19 regarding hyper-inflammation mechanism is required. Currently, development of novel anti-viral agents and vaccines are the main issues. However, it needs long time, from months to years, until suitable new medications and vaccines have been developed. An immune-modulatory tetra deca peptide (14-mer peptide) named Human Ezrin Peptide 1 (HEP-1) (trade name Gepon) was introduced by the group of Ataullakhanov in Russia. Regarding its proved anti-viral and anti-inflammatory effect, Russian authorities approved Gepon for treatment of ulcerative colitis treatment and Hepatitis -C.

Dosing Details
You inject 2ml water into the vial of HEP-1 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 0.4 on the syringe and inject it into the tummy under the skin into the fatty skin layer every 12 hours until symptoms go away. Then the maintenance dose needed is 0.1 on the syringe for 10 days thereafter.

How long will a vial last ?
A vial used for starting dose should last around 2.5 days. Maintenance protocol, a vial lasts 20 days.